Transplantation of kidneys from HCV viremic donors to HCV viremic recipients followed by early direct acting anti ‐viral therapy without ribavirin

ConclusionWe observed that HCV viremic recipients undergoing KT from a viremic donor followed by the initiation of DAA therapy without ribavirin was safe and efficacious. In the DAA era, the utilization of HCV positive organs has the potential to decrease waitlist times, expand the donor pool, and improve survival.This article is protected by copyright. All rights reserved.
Source: Journal of Viral Hepatitis - Category: Infectious Diseases Authors: Tags: Short Communication Source Type: research